The Effect of Preoperative Education on Postoperative Healing Quality in Patients With Mastectomy
Conditions:   Mastectomy; Lymphedema;   Breast Cancer Intervention:   Other: Supportive care and education before surgery Sponsor:   Saglik Bilimleri Universitesi Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials

Delayed Selective Sentinel Node Biopsy for Patients Undergoing Mastectomy for DCIS
Condition:   DCIS Intervention:   Procedure: Delay sentinel node biopsy Sponsor:   Seoul National University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials

The Effect of Preoperative Education on Postoperative Healing Quality in Patients With Mastectomy
Conditions:   Mastectomy; Lymphedema;   Breast Cancer Intervention:   Other: Supportive care and education before surgery Sponsor:   Saglik Bilimleri Universitesi Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials

Delayed Selective Sentinel Node Biopsy for Patients Undergoing Mastectomy for DCIS
Condition:   DCIS Intervention:   Procedure: Delay sentinel node biopsy Sponsor:   Seoul National University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials

The Effect of Preoperative Education on Postoperative Healing Quality in Patients With Mastectomy
Conditions:   Mastectomy; Lymphedema;   Breast Cancer Intervention:   Other: Supportive care and education before surgery Sponsor:   Saglik Bilimleri Universitesi Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials

LS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast Cancer
Conditions:   Breast Cancer;   DCIS;   Invasive Duct Carcinoma of Breast Interventions:   Drug: LS301-IT 0.025 mg/kg;   Drug: LS301-IT 0.05 mg/kg;   Drug: LS301-IT 0.075 mg/kg;   Drug: LS301-IT 0.1 mg/kg Sponsor:   Integro Theranostics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 13, 2023 Category: Research Source Type: clinical trials